Skip to content

Clinical trials

Completed Schizophrenia trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: Australia Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20022
20031
20042
20062
20071
20082
20091
20104
20114
20125
20132
20151
20171
20181
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Alfred6
Bayside Health3
FORUM Pharmaceuticals Inc3
Hoffmann-La Roche3
Janssen Research & Development, LLC3
AstraZeneca2
Boehringer Ingelheim2
Eli Lilly and Company2
Melbourne Health2
Otsuka Pharmaceutical Development & Commercialization, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia35
Psychotic Disorders13
Mental Disorders4
Cognition Disorders3
Affective Disorders, Psychotic1
Bipolar Disorder1
Depressive Disorder1
Disease1
Major Depressive Disorder1
Mood Disorders1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.